Expression of phosphorylated forms of ERK, MEK, PTEN and PI3K in mouse oral development

Kyoung-Won Cho1, Sung-Won Cho, Jong-Min Lee

  • 1Division in Anatomy and Developmental Biology, Department of Oral Biology, Research Center for Orofacial Hard Tissue Regeneration, Brain Korea 21 project, College of Dentistry, Yonsei University, Seodaemoon-Gu, Seoul, Republic of Korea.

Insights

This study reveals opposing activation patterns of phosphorylated ERK (pERK) and PTEN (pPTEN) in mouse oral development. These findings shed light on crucial molecular mechanisms regulating craniofacial growth.

Area of Science:

  • Molecular Biology
  • Developmental Biology
  • Genetics

Background:

  • Growth factors are key regulators of cellular processes like proliferation and differentiation in vertebrates.
  • Signaling pathways such as MEK/ERK and PI3K/PTEN are crucial for development but their role in oral development is unclear.
  • Understanding these pathways is essential for comprehending craniofacial development.

Purpose of the Study:

  • To investigate the expression of key signaling molecules during mouse oral development.
  • To elucidate the roles of MEK/ERK and PI3K/PTEN pathways in craniofacial development.
  • To identify unique and overlapping expression patterns of these pathways in the developing tooth and tongue.

Main Methods:

  • Examined the expression of phosphorylated ERK (pERK), MEK (pMEK), PTEN (pPTEN), and PI3K.
  • Analyzed expression during mouse embryonic development from E13.5 to E16.5.
  • Focused on the craniofacial region, specifically the tooth and tongue.

Main Results:

  • Found unique and overlapping expression patterns of pERK, pMEK, pPTEN, and PI3K in the craniofacial region.
  • Observed opposing activation patterns between pERK and pPTEN in both the developing tooth and tongue.
  • Highlighted the differential involvement of these signaling pathways in oral structures.

Conclusions:

  • The study provides novel insights into the molecular mechanisms governing mouse oral development.
  • Opposing activation of pERK and pPTEN suggests complex regulatory interactions in craniofacial development.
  • Further research is warranted to fully understand the implications of these pathways for oral and craniofacial development.

Related Concept Videos

PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a rapamycin-insensitive companion...
MAPK Signaling Cascades01:07

MAPK Signaling Cascades

Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...